About Mithra

You are here: / / About Mithra

    Specialists in women’s health

    Transforming options for women through innovation

    Mithra (Euronext: MITRA) is a Belgian biotech company dedicated to transforming Women’s Health by offering new choices through innovation, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. Its three lead development candidates are built on Mithra’s unique native estrogen platform, Estetrol (E4): Estelle®, a new era in oral contraception, PeriNesta®, the first complete oral treatment for perimenopause and Donesta®, the next-generation hormone therapy. Mithra also develops and manufactures complex therapeutics in the areas of contraception, menopause and hormone-dependent cancers. It offers partners a complete spectrum of research, development and specialist manufacturing at its technological platform Mithra CDMO.

    Our Mission is to develop innovative products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span.

    Today, Mithra has two complementary platforms powered by a unique CDMO facility: its innovative E4-based pipeline and its portfolio of complex therapeutics

    Estetrol (E4) based projects

    E4 is a naturel oestrogen produced by the human foetus during pregnancy. Mithra believes E4 has potential benefits over current estrogens in key areas including oral contraception and hormone therapy (HT).

    Mithra is focused on the development of three late-stage E4-based products : Estelle®, a new era in combined oral contraception, PeriNesta™, the first complete oral treatment for perimenopause and Donesta®, a next-generation hormone therapy for VMS in menopause.

    More

    Complex therapeutics

    Mithra also has extensive expertise in the development of complex and innovative products, using medical polymer technology.

    Mithra is developing a contraceptive vaginal ring (Myring™), a biodegradable subcutaneous implant (Zoreline®) for hormone dependant cancer. In 2016, the company also launched Tibelia®, a therapeutic solution composed of tibolone for menopause.

    More

    Mithra CDMO

    A fully integrated ecosystem for state-of-the-art research, development & manufacturing.

    Mithra CDMO is a unique facility specialized in polymeric forms, sterile injectables and hormonal tablets.

    More

    The name Mithra refers to the Persian god worshipped for 4,000 years and means “contract, partner, ally”. In Greco-Roman mythology, Mithra slew the bull and restored the reign of fertility and abundance.

    The bull is itself the symbol of the city of Liège. Mithra and the values that the name conveys are embedded in the company’s DNA.

    Subscribe to our mailing list